Browsing by author Syrjänen, S. Subscribe author statistics Syrjänen, S.
Showing results 1 to 7 of 7.
|2012||Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models||Syrjänen, K.; Shabalova, I.; Sarian, L. O., et al.||Article||Restricted access (UMinho)|
|Apr-2008||Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort||Syrjänen, K.; Naud, P.; Derchain, S., et al.||Article||Restricted access (Author)|
|Sep-2005||Evaluation of visual inspection with acetic acid (VIA), Lugol’s iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America||Sarian, L. O.; Derchain, S. F.; Naud, P., et al.||Article||Open access|
|2011||Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN||Longatto Filho, Adhemar; Hammes, L. Serpa; Sarian, L., et al.||Article||Open access|
|Oct-2012||Longitudinal outcomes of high-risk human papillomavirus (HPV) infections as competing-risks events following cervical HPV test at baseline visit in the *NIS-LAMS** cohort||Syrjänen, K.; Shabalova, I.; Sarian, L., et al.||Article||Restricted access (UMinho)|
|2008||Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study||Derchain, S. F.; Sarian, L. O.; Naud, P., et al.||Article||Open access|
|2008||Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study||Longatto, Adhemar; Roteli-Martins, C.; Hammes, L., et al.||Article||Open access|